Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.). (Q34634353)

3 August 2017

1 reference

title

Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.). (English)

1 reference

3 August 2017

Silybum marianum

1 reference

Carmen Tamayo

1

1 reference

PubMed ID

17548793

3 August 2017

Suzanne Diamond

series ordinal

2

1 reference

3 August 2017

1 June 2007

1 reference

Integrative Cancer Therapies

3 August 2017

1 reference

3 August 2017

6

1 reference

3 August 2017

2

1 reference

3 August 2017

146-157

1 reference

Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication.

3 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Silymarin treatment of viral hepatitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Milk thistle for the treatment of liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

The use of silymarin in the treatment of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Coadministration of milk thistle and indinavir in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Flavonoid antioxidant silymarin and skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Potential utility of natural polyphenols for reversing fat-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Study of the hypoglycaemic activity of Fraxinus excelsior and Silybum marianum in an animal model of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Silibinin efficacy against human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301942

21 January 2018

Identifiers

DOI

10.1177/1534735407301942

1 reference

3 August 2017

1 reference

PubMed ID

17548793